Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

ClinicalTrials.gov ID: NCT00623480

Public ClinicalTrials.gov record NCT00623480. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 1:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Controlled, Parallel, Prospective Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects, as Applicable, Compared to That of Episodic Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the effect of secondary prophylaxis as compared to episodic treatment on bleeding frequency (number of bleeds per year) and on joint damage.

Study identification

NCT ID
NCT00623480
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
84 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
12 Years to 50 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2008 (Type not available)
Primary completion
Sep 2011 (Actual)
Completion
Nov 2013 (Actual)
Last update posted
Nov 17, 2014

2008 – 2013

United States locations

U.S. sites
28
U.S. states
24
U.S. cities
26
Facility City State ZIP Site status
Not listed Tucson Arizona 85724 —
Not listed Little Rock Arkansas 72202 —
Not listed Orange California 92868 —
Not listed Sacramento California 95817 —
Not listed Aurora Colorado 80045 —
Not listed Washington D.C. District of Columbia 20007-2197 —
Not listed Orlando Florida 32801 —
Not listed Atlanta Georgia 30322 —
Not listed Chicago Illinois 60611 —
Not listed Chicago Illinois 60612 —
Not listed Indianapolis Indiana 46260 —
Not listed Iowa City Iowa 52242-1089 —
Not listed Louisville Kentucky 40202 —
Not listed Boston Massachusetts 02115 —
Not listed Detroit Michigan 48201-2196 —
Not listed Minneapolis Minnesota 55455 —
Not listed Kansas City Missouri 64108 —
Not listed Las Vegas Nevada 89109-2803 —
Not listed Newark New Jersey 07112 —
Not listed New York New York 10029 —
Not listed New York New York 10065 —
Not listed Cleveland Ohio 44106 —
Not listed Hershey Pennsylvania 17033-0850 —
Not listed Pittsburgh Pennsylvania 15213 —
Not listed Knoxville Tennessee 37920 —
Not listed Houston Texas 77030 —
Not listed Salt Lake City Utah 84132 —
Not listed Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00623480, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2014 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00623480 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →